1.
|
8 p, 318.7 KB |
Knowledge, attitudes and preferences among spanish community pharmacists regarding inhaled therapy (The optim pharmacy study)
/
Giner, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Roura, Pere (Hospital General de Vic) ;
Torres, Berta ;
Burgos, Felip (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Castillo, Diego (Institut d'Investigació Biomèdica Sant Pau) ;
Tarragona, Eduard (Chiesi España) ;
Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
To assess knowledge, attitudes, and preferences regarding inhaled therapy among Spanish community pharmacists. An 11-item questionnaire was developed and distributed to community pharmacists throughout the country. [...]
2016 - 10.22159/ijpps.2016v8i9.11796
International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8 Núm. 9 (2016) , p. 53-60
|
|
2.
|
|
SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021)
/
Remon, J. (HM Hospitales) ;
Bernabé, Reyes (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Diz, P. (Hospital Universitario de León) ;
Felip, Enriqueta (Vall d'Hebron Institut d'Oncologia) ;
González-Larriba, J.L. (Hospital Universitario Clínico San Carlos) ;
Lázaro, M. (Hospital Alvaro Cunqueiro) ;
Mielgo-Rubio, X. (Hospital Universitario Fundación Alcorcón) ;
Sánchez, A. (Consorcio Hospitalario Provincial de Castellón) ;
Sullivan, Ivana (Institut d'Investigació Biomèdica Sant Pau) ;
Massutti, B. (Hospital General Universitario de Alicante) ;
Universitat Autònoma de Barcelona
Thymic epithelial tumours (TET) represent a heterogeneous group of rare malignancies that include thymomas and thymic carcinoma. Treatment of TET is based on the resectability of the tumour. If this is considered achievable upfront, surgical resection is the cornerstone of treatment. [...]
2022 - 10.1007/s12094-022-02788-w
Clinical & Translational Oncology, Vol. 24 Núm. 4 (april 2022) , p. 635-645
|
|
3.
|
9 p, 902.3 KB |
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients : an exploratory longitudinal study
/
Viñolas, Nuria (Hospital Clínic i Provincial de Barcelona) ;
Garcia-Campelo, R. (Complejo Hospitalario Universitario de A Coruña) ;
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Carcereny, Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Isla, D. (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Gonzalez-Larriba, J.L. (Hospital Clínico San Carlos (Madrid)) ;
Coves, Juan (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
De-Castro, J. (Hospital Universitario La Paz (Madrid)) ;
Domine, M. (Hospital Universitario Fundación Jiménez Díaz) ;
Lianes, P. (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Artal, A. (Hospital Universitario Miguel Servet (Saragossa)) ;
Remon, J. (CIOCC Barcelona - HM Delfos) ;
Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ;
Garrido, P. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Universitat Autònoma de Barcelona
Little is known about the impact of sex on lung cancer patients from the psychological, economic and social perspectives. This study was designed to explore the psychosocial and economic impact according to sex of metastatic non-small cell lung cancer (mNSCLC) in patients and caregivers. [...]
2020 - 10.1186/s40359-020-00489-z
BMC Psychology, Vol. 8 Núm. 1 (december 2020) , p. 123
|
|
4.
|
14 p, 928.6 KB |
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
/
Sabaté, Mònica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pérez, Eulàlia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia Doladé, Núria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vidal Guitart, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Carreras Soler, Maria Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Farriols Danés, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Felip, Enriqueta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Braña, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Carles, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Morales-Barrera, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Muñoz Couselo, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Agustí Escasany, M. Antònia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Data related to adverse drug reactions (ADRs), specifically immune-related adverse events (irAEs), in long-term treatment with immunotherapy in real-world practice is scarce, as is general information regarding the management of ADRs. [...]
2022 - 10.3389/fmed.2022.891179
Frontiers in Medicine, Vol. 9 (august 2022)
|
|
5.
|
9 p, 1.4 MB |
Antisite Defects and Chemical Expansion in Low-damping, High-magnetization Yttrium Iron Garnet Films
/
Santiso, José (Institut Català de Nanociència i Nanotecnologia) ;
García, Carlos (Universidad Técnica Federico Santa María) ;
Romanque, Cristian (Universidad Técnica Federico Santa María) ;
Henry, Loïc (Université Grenoble Alpes) ;
Bernier, Nicolas (Université Grenoble Alpes) ;
Bagués Salgueró, Núria (The Ohio State University) ;
Caicedo Roque, Jose Manuel (Institut Català de Nanociència i Nanotecnologia) ;
Valvidares, Manuel (ALBA Laboratori de Llum de Sincrotró) ;
Sandiumenge Ortiz, Felip (Institut de Ciència de Materials de Barcelona)
Yttrium iron garnet is widely investigated for its suitability in applications ranging from magneto-optical and microwave devices to magnonics. However, in the few-nanometer thickness range, epitaxial films exhibit a strong variability in magnetic behavior that hinders their implementation in technological devices. [...]
2023 - 10.1002/cnma.202200495
ChemNanoMat, Vol. 9, Issue 2 (February 2023) , art. e202200495
|
|
6.
|
9 p, 1.1 MB |
Conventional and digital Ki67 evaluation and their correlation with molecular prognosis and morphological parameters in luminal breast cancer
/
Pons, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Hernández-León, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Altaleb, Ahmad (Mubarak Al-Kabeer Hospital, Jabriya, Kuwait) ;
Ussene, Esperança (Hospital Vila Franca de Xira, Portugal) ;
Iglesias, Roman (Hospital Santa Barbara, Ciudad Real) ;
Castillo, Ana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rodríguez-Martínez, Paula (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Castellà Fernández, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Quiroga, Vanesa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Felip, Eudald (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cirauqui, Beatriz (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Margelí, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Fernández, Pedro Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Digital counting methods were developed to decrease the high intra- and inter-observer variability of immunohistochemical markers such as Ki67, with most presenting a good correlation coefficient (CC). [...]
2022 - 10.1038/s41598-022-11411-5
Scientific reports, Vol. 12 (may 2022)
|
|
7.
|
12 p, 1.0 MB |
Self-filling enclosures to experimentally assess plankton response to pulse nutrient enrichments
/
Giménez-Grau, Pau (Centre de Recerca Ecològica i d'Aplicacions Forestals) ;
Camarero, Lluís (Centre d'Estudis Avançats de Blanes) ;
Palacín-Lizarbe, Carlos (Centre de Recerca Ecològica i d'Aplicacions Forestals) ;
Sala-Faig, Marc (Centre de Recerca Ecològica i d'Aplicacions Forestals) ;
Zufiaurre, Aitziber (Centre de Recerca Ecològica i d'Aplicacions Forestals) ;
Pla-Rabes, Sergi (Centre de Recerca Ecològica i d'Aplicacions Forestals) ;
Felip, Marisol (Centre de Recerca Ecològica i d'Aplicacions Forestals) ;
Catalán, Jordi (Centre de Recerca Ecològica i d'Aplicacions Forestals)
Experimental nutrient additions are a fundamental approach to investigating plankton ecology. Possibilities range from whole-lake fertilization to flask assays encompassing a trade-off between closeness to the "real world" and feasibility and replication. [...]
2023 - 10.1093/plankt/fbac074
Journal of Plankton Research, Vol. 45, Issue 2 (March 2023) , p. 266-277
|
|
8.
|
18 p, 6.6 MB |
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation
/
Ezeonwumelu, I.J (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
García Vidal, Edurne (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Felip, Eudald (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Puertas, Maria C. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Oriol-Tordera, Bruna (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Gutiérrez-Chamorro, Lucía (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Gohr, André (Max Planck Institute of Molecular Cell Biology and Genetics) ;
Ruiz Riol, Marta (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Massanella, Marta (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Badia, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Riveira-Muñoz, Eva (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Ballana, Ester (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Universitat Autònoma de Barcelona
The persistence of latent HIV reservoirs allows for viral rebound upon antiretroviral therapy interruption, hindering effective HIV-1 cure. Emerging evidence suggests that modulation of innate immune stimulation could impact viral latency and contribute to the clearing of HIV reservoir. [...]
2022 - 10.3389/fimmu.2022.1001068
Frontiers in immunology, Vol. 13 (september 2022)
|
|
9.
|
17 p, 1.4 MB |
Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study
/
Hernandez, Ainhoa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Boigues Pons, Marc (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Felip, Eudald (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cucurull, Marc (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Notario, Lucia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pous, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Torres, Pere (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Benitez, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rodriguez, Marina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Quirant, Bibiana (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Romeo, Margarita (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Fuster, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Moran, Teresa (Universitat Autònoma de Barcelona. Departament de Medicina)
During the SARS-CoV-2 pandemic, lung cancer patients have been considered an especially vulnerable population and have been prioritized for vaccination. However, several aspects (degree of immunity, potential interaction with active anticancer therapy, safety, and tolerability of the vaccines) remained unclear. [...]
2022 - 10.3390/cancers15010137
Cancers, Vol. 15, Num. 1 (January 2022) , art. 137
|
|
10.
|
18 p, 8.9 MB |
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
/
Zacarías-Fluck, Mariano F (Vall d'Hebron Institut d'Oncologia) ;
Massó Vallés, Daniel (Vall d'Hebron Institut d'Oncologia) ;
Giuntini, Fabio (Vall d'Hebron Institut d'Oncologia) ;
González-Larreategui, Íñigo (Vall d'Hebron Institut d'Oncologia) ;
Kaur, Jastrinjan (Vall d'Hebron Institut d'Oncologia) ;
Casacuberta-Serra, Sílvia (Vall d'Hebron Institut d'Oncologia) ;
Jauset, Toni (Vall d'Hebron Institut d'Oncologia) ;
Martínez-Martín, Sandra (Vall d'Hebron Institut d'Oncologia) ;
Martín-Fernández, Génesis (Vall d'Hebron Institut d'Oncologia) ;
Serrano del Pozo, Erika (Vall d'Hebron Institut d'Oncologia) ;
Foradada Felip, Laia (Vall d'Hebron Institut d'Oncologia) ;
Grueso, Judit (Vall d'Hebron Institut d'Oncologia) ;
Nonell, Lara (Vall d'Hebron Institut d'Oncologia) ;
Beaulieu, Marie-Eve (Vall d'Hebron Institut d'Oncologia) ;
Whitfield, Jonathan R. (Vall d'Hebron Institut d'Oncologia) ;
Soucek, Laura (Vall d'Hebron Institut d'Oncologia) ;
Universitat Autònoma de Barcelona
MYC's key role in oncogenesis and tumor progression has long been established for most human cancers. In melanoma, its deregulated activity by amplification of 8q24 chromosome or by upstream signaling coming from activating mutations in the RAS/RAF/MAPK pathway-the most predominantly mutated pathway in this disease-turns MYC into not only a driver but also a facilitator of melanoma progression, with documented effects leading to an aggressive clinical course and resistance to targeted therapy. [...]
2023 - 10.1101/gad.350078.122
Genes & Development, Vol. 37 (april 2023) , p. 303-320
|
|